© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
November 12th 2019
Michael D. Offin, MD, discusses targeted agents in MET- and RET-altered non–small cell lung cancer.
October 22nd 2019
Michael D. Offin, MD, discusses the potential implications of introducing biosimilars into the field of oncology.